Intratumoral Vaccination with Vaccinia-Expressed Tumor Antigen and Granulocyte Macrophage Colony-Stimulating Factor Overcomes Immunological Ignorance to Tumor Antigen

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6956-6961

  Yang, Arvin S ^a   Monken, Claude E ^a   Lattime, Edmund C ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHROMIUM 51; COMPLEMENTARY DNA; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HY ANTIGEN; KEYHOLE LIMPET HEMOCYANIN; TUMOR ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; LYMPH NODE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; TRANSITIONAL CELL CARCINOMA; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; CANCER VACCINES; CARCINOMA, TRANSITIONAL CELL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; H-Y ANTIGEN; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; SEX FACTORS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; URINARY BLADDER NEOPLASMS; VACCINIA;

EID: 0142188693     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chen, L. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol. Today 19: 27-30, 1998.
2. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., and Ohashi, P. S. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med., 186: 645-653, 1997.
3. Hermans, I., Daish, A., Yang, J., Ritchie, D., and Ronchese, F. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors. Cancer Res., 58: 3909-3917, 1998.
4. Ochsenbein, A. F., Klenerman, P., Karrer. U., Ludewig, B., Pericin, M., Hengartner, H., and Zinkernagel, R. M. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. USA, 96: 2233-2238, 1999.
5. Bai, X. F., Gao, J. X., Liu, J., Wen, J., Zheng, P., and Liu, Y. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Cancer Res., 61: 6860-6867, 2001.
6. Spiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y. X., and Schreiber, H. Increasing tumor antigen expression overcomes "ignorance" to solid tumors via Cross-presentation by bone marrow-derived stromal cells. Immunity. 17: 737-747, 2002.
7. Enk, A. H., Jonuleil, H., Saloga, J., and Knop, J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer, 73: 309-316, 1997.
8. Greenfield, A., Scott, D., Pennisi, D., Ehrmann, I., Ellis, P., Cooper, L., Simpson, E., and Koopman, P. An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nat. Genet., 14: 474-478, 1996.
9. Chakrabarti, S., Sisler, J. R., and Moss, B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques, 23: 1094-1097, 1997.
10. Eisenlohr, L. C., Yewdell, J. W., and Bennink, J. R. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med., 175: 481-487, 1992.
11. McAveney, K. M., Gomella, L. G., and Lattime, E. C. Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy. Cancer Immunol. Immunother., 39: 401-406, 1994.
12. Simpson, E., Scott, D., and Chandler, P. The male-specific histocompatibility antigen. H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol., 15: 39-61, 1997.
13. Melief, C. J. Tumor eradication by adoptive transfer of cylotoxic T lymphocytes. Adv. Cancer Res., 58: 143-175, 1992.
14. Halak, B. K., Maguire, H. C., Jr., and Lattime, E. C. Tumor-induced interleukin-10 inhibits type I immune responses directed at a tumor-antigen as well as a non-tumor antigen present at the tumor site. Cancer Res., 59: 911-917, 1999.
15. Borrello, I., and Pardoll, D. GM-CSF-based cellular vaccines: a review of the clinical experience. Cytokine Growth Factor Rev., 13: 185-193, 2002.
16. Chen, Y., Lin, S. M., Lai, H. S., Tseng, S. H., and Chen, W. J. Effects of irradiated tumor vaccine and continuous localized infusion of granulocyte-macrophage colony-stimulating factor on neuroblastomas in mice. J. Pediatr. Surg., 37: 1298-1304, 2002.
17. Marzo, A. L., Lake, R. A., Lo, D., Sherman, L., McWilliam, A., Nelson, D., Robinson, B. W., and Scott, B. Tumor antigens are constitutively presented in the draining lymph nodes. J. Immunol., 162: 5838-5845, 1999.
18. Shrikant, P., and Mescher, M. F. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol. 162: 2858-2866, 1999.
19. Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., and Allen, P. M. Eradication of established tumors by CD8+ T-cell adoptive immunotherapy. Immunity, 13: 265-276, 2000.
20. Yang, A. S., and Lattime, E. C. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res., 63: 2150-2157, 2003.
21. Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., and Schreiber, H. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med., 186: 229-238, 1997.
22. Radoja, S., Rao, T. D., Hillman, D., and Frey, A. B. Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo. J. Immunol., 164: 2619-2628, 2000.